BC
MRK icon

Birchview Capital’s Merck MRK Stock Holding History

Birchview Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-10,480
Closed -$640K – 43
2017
Q3 		$640K Hold
10,480
– – 0.33% 22
2017
Q2 		$641K Sell
10,480
-5,240
-33% -$319K 0.34% 22
2017
Q1 		$953K Hold
15,720
– – 0.53% 12
2016
Q4 		$883K Hold
15,720
– – 0.54% 12
2016
Q3 		$936K Hold
15,720
– – 0.55% 11
2016
Q2 		$864K Hold
15,720
– – 0.63% 14
2016
Q1 		$794K Hold
15,720
– – 0.57% 14
2015
Q4 		$792K Hold
15,720
– – 0.46% 17
2015
Q3 		$741K Hold
15,720
– – 0.48% 18
2015
Q2 		$854K Hold
15,720
– – 0.45% 19
2015
Q1 		$862K Hold
15,720
– – 0.45% 20
2014
Q4 		$852K Buy
+15,720
New +$876K 0.49% 20

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Birchview Capital's MRK Position: Q4 2017 in Review

Birchview Capital sold out of Merck (MRK) in Q4 2017, closing a stake of 10,480 shares — an estimated $640K sold.

Birchview Capital first reported a position in MRK in Q4 2014 and held it in 12 quarters. The position peaked at $953K in Q1 2017. 2,008 funds tracked by Wall St. Rank hold MRK as of Q4 2017.

  • Birchview Capital reported no remaining Merck position as of Q4 2017 after selling out during the quarter.
  • Birchview Capital sold 10,480 Merck shares in Q4 2017, an estimated $640K.
  • Birchview Capital first reported a position in Merck in Q4 2014 and held it in 12 quarters.
  • Birchview Capital's Merck position peaked at $953K in Q1 2017.
  • 2,008 funds tracked by Wall St. Rank held Merck as of Q4 2017.

Based on Birchview Capital's 13F filing for Q4 2017, filed 2 Feb 2018.